Albireo Pharma, Inc.
(NASDAQ CM: ALBO)
Rigrodsky Law, P.A. is investigating Albireo Pharma, Inc. (“Albireo”) regarding possible breaches of fiduciary duties and other violations of law related to Albireo’s agreement to be acquired by Ipsen Biopharmaceuticals, Inc.